Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00375115Phase 4Completed
Phase 4, randomised, double-blind trial of elderberry in influenza, sponsored by Hadassah Medical Organization. Primary endpoint: Length of time to resolution of influenza illness at 10 days. Started Sep 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00375115.